Literature DB >> 27033126

Diagnosis and management of chronic constipation in adults.

Satish S C Rao1, Kulthep Rattanakovit1, Tanisa Patcharatrakul1.   

Abstract

Constipation is a heterogeneous, polysymptomatic, multifactorial disease. Acute or transient constipation can be due to changes in diet, travel or stress, and secondary constipation can result from drug treatment, neurological or metabolic conditions or, rarely, colon cancer. A diagnosis of primary chronic constipation is made after exclusion of secondary causes of constipation and encompasses several overlapping subtypes. Slow-transit constipation is characterized by prolonged colonic transit in the absence of pelvic floor dysfunction. This subtype of constipation can be identified using either the radio-opaque marker test or wireless motility capsule test, and is best treated with laxatives such as polyethylene glycol or newer agents such as linaclotide or lubiprostone. If unsuccessful, subspecialist referral should be considered. Dyssynergic defecation results from impaired coordination of rectoanal and pelvic floor muscles, and causes difficulty with defecation. The condition can be identified using anorectal manometry and balloon expulsion tests and is best managed with biofeedback therapy. Opioid-induced constipation is an emerging entity, and several drugs including naloxegol, methylnaltrexone and lubiprostone are approved for its treatment. In this Review, we provide an overview of the burden and pathophysiology of chronic constipation, as well as a detailed discussion of the available diagnostic tools and treatment options.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27033126     DOI: 10.1038/nrgastro.2016.53

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN: 1759-5045            Impact factor:   46.802


  105 in total

1.  Open-magnet MR defaecography compared with evacuation proctography in the diagnosis and management of patients with rectal intussusception.

Authors:  L S Dvorkin; F Hetzer; S M Scott; N S Williams; W Gedroyc; P J Lunniss
Journal:  Colorectal Dis       Date:  2004-01       Impact factor: 3.788

2.  Pathophysiology and role of biofeedback therapy in solitary rectal ulcer syndrome.

Authors:  Satish S C Rao; Ramazan Ozturk; Sherrie De Ocampo; Mary Stessman
Journal:  Am J Gastroenterol       Date:  2006-02-08       Impact factor: 10.864

Review 3.  Biofeedback therapy for defecation disorders.

Authors:  S S Rao; P Enck; V Loening-Baucke
Journal:  Dig Dis       Date:  1997       Impact factor: 2.404

Review 4.  American Gastroenterological Association Institute Technical Review on the pharmacological management of irritable bowel syndrome.

Authors:  Lin Chang; Anthony Lembo; Shahnaz Sultan
Journal:  Gastroenterology       Date:  2014-09-16       Impact factor: 22.682

5.  Treatment efficacy of sacral nerve stimulation in slow transit constipation: a two-phase, double-blind randomized controlled crossover study.

Authors:  Phil G Dinning; Linda Hunt; Vicki Patton; Teng Zhang; Michal Szczesniak; Val Gebski; Mike Jones; Peter Stewart; David Z Lubowski; Ian J Cook
Journal:  Am J Gastroenterol       Date:  2015-04-21       Impact factor: 10.864

Review 6.  Colonic motility in man: features in normal subjects and in patients with chronic idiopathic constipation.

Authors:  G Bassotti; G Iantorno; S Fiorella; L Bustos-Fernandez; C R Bilder
Journal:  Am J Gastroenterol       Date:  1999-07       Impact factor: 10.864

Review 7.  Short-chain carbohydrates and functional gastrointestinal disorders.

Authors:  Susan J Shepherd; Miranda C E Lomer; Peter R Gibson
Journal:  Am J Gastroenterol       Date:  2013-04-16       Impact factor: 10.864

8.  Diagnostic testing for dyssynergic defecation in chronic constipation: meta-analysis.

Authors:  E J Videlock; A Lembo; F Cremonini
Journal:  Neurogastroenterol Motil       Date:  2013-02-20       Impact factor: 3.598

9.  Long-term safety and effectiveness of lubiprostone, a chloride channel (ClC-2) activator, in patients with chronic idiopathic constipation.

Authors:  Anthony J Lembo; John F Johanson; Henry P Parkman; Satish S Rao; Philip B Miner; Ryuji Ueno
Journal:  Dig Dis Sci       Date:  2011-07-19       Impact factor: 3.199

10.  An Update on Post-infectious Irritable Bowel Syndrome: Role of Genetics, Immune Activation, Serotonin and Altered Microbiome.

Authors:  Robin Spiller; Ching Lam
Journal:  J Neurogastroenterol Motil       Date:  2012-07-10       Impact factor: 4.924

View more
  66 in total

1.  Home Biofeedback for the Treatment of Dyssynergic Defecation: Does It Improve Quality of Life and Is It Cost-Effective?

Authors:  Satish S C Rao; Jorge T Go; Jessica Valestin; John Schneider
Journal:  Am J Gastroenterol       Date:  2019-06       Impact factor: 10.864

2.  The evaluation of GI-pill gastrointestinal electronic capsule for colonic transit test in patients with slow transit constipation.

Authors:  Yong-Bing Wang; Gang Li; Yun-Feng Wang; Yu-Jiang Ding; Guo-Zheng Yan; Ding Han; Zhi-Wu Wang; Xiao-Hui Zhao
Journal:  Int J Colorectal Dis       Date:  2019-11-22       Impact factor: 2.571

3.  Pretest and Post-test Probabilities of Diagnoses of Rectal Evacuation Disorders Based on Symptoms, Rectal Exam, and Basic Tests: a Systematic Review.

Authors:  Justin Brandler; Michael Camilleri
Journal:  Clin Gastroenterol Hepatol       Date:  2019-12-04       Impact factor: 11.382

Review 4.  Targeting Small Bowel Receptors to Treat Constipation and Diarrhea.

Authors:  Elizabeth S John; Sita Chokhavatia
Journal:  Curr Gastroenterol Rep       Date:  2017-07

5.  The Sphincter of O'Beirne-Part 2: Report of a Case of Chronic Constipation with Autonomous Dyssynergia.

Authors:  Ji-Hong Chen; Stephen M Collins; Natalija Milkova; Maham Pervez; Sharjana Nirmalathasan; Wei Tan; Alicia Hanman; Jan D Huizinga
Journal:  Dig Dis Sci       Date:  2021-01-19       Impact factor: 3.199

6.  Clinical Assessment of Gastrointestinal Involvement in Patients with Systemic Sclerosis.

Authors:  Timothy Kaniecki; Tsion Abdi; Zsuzsanna H McMahan
Journal:  Med Res Arch       Date:  2020-10-29

7.  4,8-Dimethylcoumarin Inhibitors of Intestinal Anion Exchanger slc26a3 (Downregulated in Adenoma) for Anti-Absorptive Therapy of Constipation.

Authors:  Sujin Lee; Onur Cil; Peter M Haggie; Alan S Verkman
Journal:  J Med Chem       Date:  2019-09-03       Impact factor: 7.446

8.  SLC26A3 inhibitor identified in small molecule screen blocks colonic fluid absorption and reduces constipation.

Authors:  Peter M Haggie; Onur Cil; Sujin Lee; Joseph-Anthony Tan; Amber A Rivera; Puay-Wah Phuan; Alan S Verkman
Journal:  JCI Insight       Date:  2018-07-26

9.  Prolonged-Release Oxycodone/Naloxone Improves Anal Sphincter Relaxation Compared to Oxycodone Plus Macrogol 3350.

Authors:  Jakob Lykke Poulsen; Christina Brock; Debbie Grønlund; Donghua Liao; Hans Gregersen; Klaus Krogh; Asbjørn Mohr Drewes
Journal:  Dig Dis Sci       Date:  2017-10-06       Impact factor: 3.199

Review 10.  Ion channelopathies in functional GI disorders.

Authors:  Arthur Beyder; Gianrico Farrugia
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-08-11       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.